Alpha Tau Medical
DRTS
Alpha Tau Medical (DRTS) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $16.00 from $15.00 | Aug 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Jul 22, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Jul 16, 2026 |
| Barclays | Maintained | Overweight | $17.00 from $15.00 | Jun 4, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Jun 4, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Jun 2, 2026 |
| Barclays | Initiated Coverage | Overweight | $15.00 | May 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | May 20, 2026 |
| Piper Sandler | Maintained | Neutral | $8.00 from $5.00 | May 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 from $12.00 | May 12, 2026 |
| Ladenburg Thalmann | Maintained | Buy | $14.00 from $12.00 | May 12, 2026 |
| Citigroup | Maintained | Buy | $9.00 from $7.00 | Mar 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Mar 10, 2026 |
| Piper Sandler | Downgraded | Overweight → Neutral | $5.00 | Mar 4, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 from $9.00 | Feb 24, 2026 |
| Citigroup | Maintained | Buy | $7.00 from $8.00 | Dec 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Nov 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Oct 22, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Sep 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Apr 29, 2025 |
Frequently asked questions
What is the latest analyst rating on DRTS?
On Aug 11, 2026, HC Wainwright & Co. maintained Alpha Tau Medical at Buy with a price target of $16.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.